Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Obviously TPL can't take every target to court, we don't have the time or money.
There won't be future Markmans after this one. There won't be anymore reexams that would update the claims to necessitate another Markman. It is that simple. All future litigation would go in front of Judge Ware as the NDoC would be the judicially efficient venue. All of the above is predicated on a favorable Markman hearing. Corrections welcome and posting cliff notes from phone.
Share
New Message
Please login to post a reply